The recurrence rate of cholangiocarcinoma after surgery

Patients with bile duct cancer and their families are very concerned about the postoperative survival period, but the patient's condition and mental state, as well as subsequent treatment, have an impact on the specific survival period. Biliary duct cancer is a malignant tumor disease, which is generally prone to recurrence and metastasis after surgery, so patients should do a good job of postoperative adjuvant treatment to avoid recurrence and metastasis. What is the recurrence rate of bile duct cancer after surgery? Let's find out together.

Cholangiocarcinoma can be divided into three types according to the high and low locations. High (hilar) cholangiocarcinoma; middle cholangiocarcinoma; low (lower) cholangiocarcinoma. The results after surgery are not exactly the same in different locations. In addition, the degree of differentiation of the tumor also affects the prognosis, that is, the recurrence rate and survival time. In addition, the nutritional status of the patient also affects the effect of surgical treatment. Therefore, it is difficult to explain the recurrence rate and survival time after cholangiocarcinoma surgery in one sentence. A comprehensive analysis and judgment is required.

After surgery for bile duct cancer, the first thing to do is to prevent recurrence, and then chemotherapy or traditional Chinese medicine treatment can be used to kill and control residual cancer cells. Modern Chinese medicine ginsenoside Rh2 (life-protecting element) has the anti-tumor effect of inhibiting the growth of cancer cells, inducing apoptosis of cancer cells, and reversing abnormal differentiation of cancer cells. It can effectively control the growth and spread of cancer cells. In addition, ginsenoside Rh2 (life-protecting element) also has the effect of improving human immunity. It can enhance the activity of T lymphocytes and phagocytes to achieve the effect of enhancing immunity, thereby enhancing the ability of human immune cells to resist cancer cell invasion, preventing the spread and metastasis of cancer cells after bile duct cancer surgery, and prolonging the patient's life.